China Approves Brain Implant for Partially Paralyzed Adults

China's drug regulator has granted marketing approval to Neuracle Technology for a brain implant designed for adult patients experiencing partial paralysis. Bloomberg posted on X, highlighting the significance of this development in the medical technology sector. The approval marks a significant step forward in the treatment options available for individuals with paralysis, potentially improving their quality of life. Neuracle Technology's innovation is expected to contribute to advancements in neurological treatments and rehabilitation.